Progenitor Therapeutics Ltd - Company Review
Progenitor Therapeutics Ltd - Company ReviewSummary
Progenitor Therapeutics Ltd (Progenitor), formerly Progenitor Labs Ltd, is a biotechnology company, which focuses on the development of small molecule drugs to regenerate organs of the human body in response to injury, disease or aging. It utilizes two technology platforms, namely, ProScreen and CombiCult, to develop novel drugs. The ProScreen platform helps develop counterparts of progenitor cells from large volumes of pluripotent stem cells. The CombiCult platform is used to identify methods of separating pluripotent stem cells such as embryonic stem (ES) or induced pluripotent stem (iPS) cells into particular cell types. Progenitor is a spin-out of Plasticell, a stem cell biotech company. Progenitor is headquartered in Stevenage, England, the UK.
This comprehensive company report of Progenitor Therapeutics Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.